1. Практическое руководство по антимикробной химиотерапии (под ред. Л.С.Страчунского). М., 2002.
2. Пальчун В.Т., Кунельская Н.Л., Кислова Н.М. Экстренная патология носа и околоносовых пазух. Вестн. оториноларингол. 1998; 3: 4–12.
3. Wolff M. Epidemiology of antibiotic resistance: implications for emprirical treatment in intensive care, Schweiz Med Wochenschr. 1995; 125 (36): 1684–6.
4. Sela S, Barzilai A. Why do we fail with penicillin in the treatment of group A streptococcus infections? Ann Med 1999; 31: 303–7.
5. Kaplan EL, Chhatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and path genetic implications. Clin Infect Dis 2006; 43 (11): 1398–406.
6. Fraschini F et al. Clin Pharmacokinet 1993; 25: 189–204.
7. Fuursted K, Knudsen JD, Petersen MB et al. Comparative study of bactericidal activities, postantibiotic effects and effects on bacterial virulence of penicillin G and six macrolides against Streptococcus pneumoniae.
8. Antimicrob Agents Chemother 1997; 41: 781–4.